Literature DB >> 6287304

Opiate receptor binding studies in the mouse vas deferens exhibiting tolerance without dependence.

P Rubini, R Schulz, M Wüster, A Herz.   

Abstract

The apparent lack of dependence in highly opiate-tolerant isolated mouse vas deferens may conflict with unitary theories postulating a common biochemical mechanism for both phenomena. Therefore, attention focused on binding sites of the opiate receptors which in this tissue are located presynaptically. Binding studies conducted with homogenate of highly tolerant vasa deferentia revealed no significant different results as compared to naive tissues. Further studies examined the effect of guanine nucleotide on opiate receptor interaction. Apparently, mu-, delta- and kappa-opiate receptors in the mouse vas deferens proved resistant to the regulatory action of guanine nucleotide in naive and tolerant tissues. From these experiments, it is concluded that the binding characteristics of opiate receptors in the mouse vas deferens do not change with chronic activation. In addition, the lack of an effect of guanine nucleotide on opiate binding leads to the suggestion that binding sites are not coupled to adenylate cyclase in this tissue. Taken together, these findings draw the attention to the coupling mechanism of opiate receptors in the mouse vas deferens which may play a key role in the adaptational mechanisms following chronic opiate exposure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287304     DOI: 10.1007/bf00503928

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Cellular site of opiate dependence.

Authors:  H O Collier
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

2.  The absence of desensitization in the beta adrenergic receptors of turkey reticulocytes and erythrocytes and its possible origin.

Authors:  E Hanski; A Levitzki
Journal:  Life Sci       Date:  1978-01       Impact factor: 5.037

3.  Supersensitivity and dependence.

Authors:  H O Collier
Journal:  Nature       Date:  1968-10-19       Impact factor: 49.962

Review 4.  Metal ion interactions with opiates.

Authors:  D B Chapman; E L Way
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

5.  Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells.

Authors:  K J Chang; R W Eckel; S G Blanchard
Journal:  Nature       Date:  1982-04-01       Impact factor: 49.962

6.  Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.

Authors:  R Schulz; M Wüster; P Rubini; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

Review 7.  Multiple opiate receptors in peripheral tissue preparations.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Biochem Pharmacol       Date:  1981-07-15       Impact factor: 5.858

8.  Differential regulation by guanine nucleotides or opiate agonist and antagonist receptor interactions.

Authors:  S R Childers; S H Snyder
Journal:  J Neurochem       Date:  1980-03       Impact factor: 5.372

9.  The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum.

Authors:  H W Kosterlitz; R J Lydon; A J Watt
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

10.  Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the ginea pig.

Authors:  F M Leslie; H W Kosterlitz
Journal:  Eur J Pharmacol       Date:  1979-07-01       Impact factor: 4.432

View more
  1 in total

1.  Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series.

Authors:  David J Daniels; Natalie R Lenard; Chris L Etienne; Ping-Yee Law; Sandra C Roerig; Philip S Portoghese
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.